Cyclooctadepsipeptides - A new class of anthelmintically active compounds

Parasitology Research

Volumn 88, Issue 6, 2002, Pages 481-488

  Harder, Achim ^a   Von Samson Himmelstjerna, Georg ^b  

^a BAYER AG   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABAMECTIN; ANTHELMINTIC AGENT; AVERMECTIN; BENZIMIDAZOLE DERIVATIVE; CAMBENDAZOLE; CYCLO(DEXTRO LACTYL N METHYLLEUCYL DEXTRO 3 PHENYLLACTYL N METHYLLEUCYL DEXTRO LACTYL N METHYLLEUCYL DEXTRO 3 PHENYLLACTYL N METHYLLEUCYL); CYCLOOCTADEPEPSIPETIDASE; DORAMECTIN; EMODEPSIDE; EPRINOMECTIN; FEBANTEL; FENBENDAZOLE; IMIDAZOLE DERIVATIVE; IVERMECTIN; LEVAMISOLE; MACROLIDE; MILBEMYCIN; MORANTEL; MOXIDECTIN; NAPHTHALENE DERIVATIVE; NICOTINIC AGENT; OXANTEL; PARBENDAZOLE; PF 1022 221; PHENOTHIAZINE DERIVATIVE; PIPERAZINE DERIVATIVE; PYRANTEL; SELAMECTIN; THIAZOLE DERIVATIVE; TIABENDAZOLE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTINEMATODAL AGENT; CYCLOPEPTIDE; DEPSIPEPTIDE;

ANTHELMINTIC ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; DIROFILARIA; DOSE RESPONSE; DRUG FORMULATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SOLUBILITY; FILARIASIS; HAEMONCHUS; HUMAN; NEMATODIASIS; NIPPOSTRONGYLUS; NONHUMAN; ONCHOCERCIASIS; PRIORITY JOURNAL; STRONGYLOIDEA; TOXOCARA CANIS; TRICHOSTRONGYLUS; WUCHERERIA BANCROFTI; ANIMAL; CHEMICAL MODEL; CHEMISTRY; CLASSIFICATION; DRUG DESIGN; DRUG RESISTANCE; METABOLISM; REVIEW; SYNTHESIS;

ANIMAL; ANTINEMATODAL AGENTS; DRUG DESIGN; DRUG RESISTANCE; MODELS, CHEMICAL; NEMATODE INFECTIONS; PEPTIDES, CYCLIC; ANIMALS; DEPSIPEPTIDES;

CANIS; DIROFILARIA; HAEMONCHUS; NIPPOSTRONGYLUS; STRONGYLOIDEA; TOXOCARA; TOXOCARA CANIS; TRICHOSTRONGYLUS; WUCHERERIA; WUCHERERIA BANCROFTI;

EID: 0036022148     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-002-0619-2     Document Type: Article

References (45)

1. Effects of PF1022A, a newly developed gabergic anthelmintic, on adult stage of Angiostrongylus cantonensis in rats
2. Can eradication of helmintic infections change the face of AIDS and tuberculosis?
3. Effects of anthelmintics with different modes of action on the behaviour and development of Caenorhabditis elegans
4. Can we deworm this wormy world?
5. Characterization of subtypes of gamma-aminobutyric acid receptors in an Ascaris muscle preparation by binding assay and binding of PF1022A, a new anthelmintic, on the receptors
6. Anthelmintic profile of the cyclodepsipeptide PF1022A in in vitro and in vivo models
7. Synthesis of PF1022A, an anthelmintic cyclodepsipeptide
8. Azadepsipeptides: Preparation and evaluation of a new class of peptidomimetics
9. Anthelmintic effects of PF1022, a new cyclic depsipeptide, on the intestinal parasitic nematodes in dogs and cats
10. Ionophorous and anthelmintic activity of PF1022A, a cyclooctadepsipeptide, are not related
11. Mechanism of action and resistance of antiprotozoal and anthelmintic drugs
12. Activity of the cyclic depsipeptide BAY 44-4400 against larval and adult stages of nematodes in rodents and the influence on worm survival
13. The four larval stages and the adults of Heterakis spumosa are impaired by the anthelmintic cyclodepsipeptide PF1022A
14. Cyclodepsipeptides: From natural product to anthelmintically active synthetic enniatins
15. Synthesis and anthelmintic activity of thioamide analogues of cyclic octadepsipeptides such as PF1022A
16. Effects of PF1022 A on Angiostrongylus cantonensis staying in the central nervous system of rats and mice
17. Effects of PF1022A on adult Angiostrongylus cantonensis in the pulmonary arteries and larvae migration into the central nervous system of rats
18. Effects of amorphous and polymorphs of PF1022A, a new antinematode drug, on Angiostrongylus costaricensis in mice
19. Synthesis and anthelmintic activity of the cyclodepsipeptide, PF1022A
20. BAY 44-4400 - A member of a novel class of cyclooctadepsipeptides with antinematodal activities
21. Solid-phase synthesis of cyclooctadepsipeptide PF1022A analogs using a cyclization-cleavage method with oxime resin
22. Anthelmintic actions of the cyclic depsipeptide PF1022A and electrophysiological effects on muscle cells of Ascaris suum
23. Perspectives in animal health: Old targets and new opportunities
24. Synergistic action of Bay 44-4400 and piperazine on nematodes of the mouse in vitro and in vivo: A light and transmission electron microscopic study
25. Total synthesis of the anthelmintic cyclodepsipeptide, PF1022A
26. 3H-methyl) PF1022A
27. 3H-methyl) JES1798
28. Latrophilin-like receptor from the parasite nematode Haemonchus contortus as target for the anthelmintic depsipeptide PF1022A
29. In vivo activities of the new anthelmintic depsipeptide PF1022A
30. Managing parasiticide resistance
31. Pharmacology of anthelmintic resistance
32. A new anthelmintic cyclodepsipeptide, PF1022A
33. A highly efficient synthesis of the anthelmintic cyclooctadepsipeptide PF1022A
34. PF1022A - A novel anthelmintic cyclooctadepsipeptide. Modification and exchange of the N-methyl leucine residues
35. Synthesis, conformational studies, and anthelmintic activity of a constrained PF1022A analogue
36. On a new cyclic depsipeptide, PF1022, with anthelmintic effects
37. Neuropharmacological mechanism of action of PF1022A, an antinematode anthelmintic with a new structure of cyclic depsipeptide, on Angiostrongylus cantonensis and isolated frog rectus
38. Effects of PF1022A on developing larvae of Angiostrongylus costaricensis in mice, with special reference to route, dose and formulation
39. Anthelmintic resistance
40. Biosynthesis of PF1022A and related cyclooctadepsipeptides
41. A possible mechanism for the action of the novel anthelmintic emodepside, using Ascaris suum body wall muscle preparations
42. Ivermectin als orale einmalbehandlung der skabies
43. Effects of BAY 44-4400, a new cyclodepsipeptide, on developing stages of filariae (Acanthocheilonema viteae, Brugia malayi, Litomosoides sigmodontis) in the rodent Mastomys coucha
44. Filaricidal efficacy of anthelmintically active cyclodepsipeptides